Stock Yards Bank & Trust’s GSK GSK Stock Holding History

Stock Yards Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Sell	5,159 -540	-9%	-$29.3K	0.01%	345
2025 Q4	$279K	Sell	5,699 -84	-1%	-$3.92K	0.01%	354
2025 Q3	$250K	Buy	+5,783	New	+$226K	0.01%	360
2025 Q2	–	Sell	-5,180	Closed	-$201K	–	389
2025 Q1	$201K	Buy	+5,180	New	+$190K	0.01%	373
2024 Q4	–	Sell	-5,130	Closed	-$210K	–	370
2024 Q3	$210K	Buy	+5,130	New	+$210K	0.01%	365
2024 Q2	–	Sell	-5,197	Closed	-$223K	–	386
2024 Q1	$223K	Buy	+5,197	New	+$214K	0.01%	375
2023 Q3	–	Sell	-7,522	Closed	-$268K	–	390
2023 Q2	$268K	Sell	7,522 -488	-6%	-$17.5K	0.01%	349
2023 Q1	$285K	Sell	8,010 -380	-5%	-$13.3K	0.01%	343
2022 Q4	$295K	Sell	8,390 -1,841	-18%	-$61.3K	0.01%	348
2022 Q3	$301K	Sell	10,231 -508	-5%	-$19.3K	0.01%	336
2022 Q2	$584K	Buy	10,739 +2,359	+28%	+$130K	0.02%	272
2022 Q1	$456K	Sell	8,380 -282	-3%	-$15.3K	0.03%	180
2021 Q4	$478K	Buy	8,662 +2,756	+47%	+$143K	0.03%	182
2021 Q3	$283K	Hold	5,906	–	–	0.02%	203
2021 Q2	$294K	Buy	5,906 +1,258	+27%	+$60.4K	0.02%	204
2021 Q1	$207K	Buy	4,648 +200	+4%	+$9.08K	0.01%	240
2020 Q4	$205K	Sell	4,448 -2,800	-39%	-$129K	0.01%	229
2020 Q3	$341K	Hold	7,248	–	–	0.03%	170
2020 Q2	$370K	Buy	7,248 +232	+3%	+$11.9K	0.03%	166
2020 Q1	$332K	Buy	7,016 +288	+4%	+$15.4K	0.04%	157
2019 Q4	$395K	Hold	6,728	–	–	0.03%	169
2019 Q3	$359K	Sell	6,728 -2,219	-25%	-$114K	0.03%	171
2019 Q2	$448K	Hold	8,947	–	–	0.04%	162
2019 Q1	$468K	Buy	8,947 +21	+0.2%	+$1.05K	0.05%	155
2018 Q4	$426K	Hold	8,926	–	–	0.05%	153
2018 Q3	$448K	Hold	8,926	–	–	0.05%	155
2018 Q2	$450K	Hold	8,926	–	–	0.05%	149
2018 Q1	$436K	Buy	8,926 +3,271	+58%	+$152K	0.05%	153
2017 Q4	$250K	Sell	5,655 -928	-14%	-$42.9K	0.03%	193
2017 Q3	$334K	Sell	6,583 -45	-0.7%	-$2.28K	0.04%	164
2017 Q2	$357K	Sell	6,628 -30	-0.5%	-$1.6K	0.04%	161
2017 Q1	$351K	Hold	6,658	–	–	0.04%	159
2016 Q4	$321K	Sell	6,658 -2,342	-26%	-$116K	0.04%	161
2016 Q3	$485K	Buy	9,000 +316	+4%	+$17.3K	0.07%	141
2016 Q2	$470K	Sell	8,684 -72	-0.8%	-$3.79K	0.06%	154
2016 Q1	$444K	Sell	8,756 -1,401	-14%	-$69.8K	0.06%	145
2015 Q4	$512K	Buy	10,157 +29	+0.3%	+$1.48K	0.07%	140
2015 Q3	$486K	Buy	10,128 +525	+5%	+$27.3K	0.07%	139
2015 Q2	$500K	Buy	9,603 +1,333	+16%	+$75.1K	0.07%	145
2015 Q1	$477K	Buy	8,270 +535	+7%	+$30.7K	0.07%	150
2014 Q4	$413K	Buy	7,735 +1,814	+31%	+$101K	0.06%	165
2014 Q3	$340K	Buy	5,921 +111	+2%	+$6.8K	0.05%	170
2014 Q2	$388K	Hold	5,810	–	–	0.06%	171
2014 Q1	$388K	Sell	5,810 -1,140	-16%	-$77.1K	0.06%	164
2013 Q4	$464K	Buy	6,950 +80	+1%	+$5.19K	0.07%	145
2013 Q3	$431K	Buy	6,870 +242	+4%	+$15.6K	0.07%	143
2013 Q2	$414K	Buy	+6,628	New	+$421K	0.05%	148

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stock Yards Bank & Trust's GSK Position: Q1 2026 in Review

Stock Yards Bank & Trust reduced its GSK (GSK) stake by 9.5% in Q1 2026, selling an estimated $29.3K and leaving 5,159 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #345.

Stock Yards Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 47 quarters since. The position peaked at $584K in Q2 2022. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Stock Yards Bank & Trust held 5,159 shares of GSK worth $285K as of Q1 2026.
Stock Yards Bank & Trust sold 540 GSK shares in Q1 2026, an estimated $29.3K.
GSK made up 0.01% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #345 holding.
Stock Yards Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 47 quarters since.
Stock Yards Bank & Trust's GSK position peaked at $584K in Q2 2022.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.